Details for 2018209821

Up to date per 03.04.2026

Actions

Title / Product Name

1,4-DISUBSTITUIERTE PYRIDAZIN-ANALOGA UND VERFAHREN ZUR BEHANDLUNG VON SMN-ASSOZIIERTEN ERKRANKUNGEN

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2018209821

EP Publication Number

3564233

E-Number

1564515

Language

PCT Number

Publication Date

06.11.2019 A

03.05.2023 B1

Registration Date

03.05.2023

AT Publication Date

15.05.2023

Application Date

13.08.2013

Registration Number

Priorities

13.08.2012

201261682448 P

IPC

C07D 401/14 20060101AFI20190830BHEP

Maximum Duration of Protection

13.08.2033

Owner

Novartis AGLichtstrasse 35 4056 BaselCH

Representative

No representatives present

Inventor

CHEUNG, AtwoodNovartis Institutes for BioMedical Research Inc. 250 Massachusetts Avenue Cambridge, Massachusetts 02139US

CHIN, Donovan NoelNovartis Institutes for BioMedical Research Inc. 100 Technology Square Cambridge, Massachusetts 02139US

DALES, NatalieNovartis Institutes for BioMedical Research Inc. 250 Massachusetts Avenue Cambridge, Massachusetts 02139US

FAZAL, AleemNovartis Institutes for BioMedical Research Inc. 250 Massachusetts Avenue Cambridge, Massachusetts 02139US

HURLEY, Timothy BrianNovartis Institutes for BioMedical Research Inc. 250 Massachusetts Avenue Cambridge, Massachusetts 02139US

KERRIGAN, JohnNovartis Institutes for BioMedical Research Inc. 250 Massachusetts Avenue Cambridge, Massachusetts 02139US

O'BRIEN, GaryNovartis Institutes for BioMedical Research Inc. 250 Massachusetts Avenue Cambridge, Massachusetts 02139US

SHU, LeiNovartis Institutes for BioMedical Research Inc. 250 Massachusetts Avenue Cambridge, Massachusetts 02139US

SUN, Robert11 Lamplight Circle Natick, Massachusetts 01760US

SUNG, MooNovartis Institutes for BioMedical Research Inc. 250 Massachusetts Avenue Cambridge, Massachusetts 02139US